01066 WEIGAO GROUP
- 5.250
- -0.090-1.69%
WEIGAO GROUP News
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)
DBS: Maintaining the “Buy” Rating of Weigao Shares (01066.HK) and reducing the target price to HK$6.4
Weigao Co., Ltd. (1066.HK): Performance under pressure due to collection and base figures
Bank Rating | Goldman Sachs: Lowering the target price of Weigao shares to HK$8.7 to maintain a “buy” rating
Weigao Co., Ltd. (01066.HK): 2023 results are in line with expectations and await a steady recovery in 2024
Changes in Hong Kong stocks | Weigao shares (01066) fell more than 5%. The company's performance last year was clearly under pressure, and CICC lowered its profit estimates and target price
Research Nuggets | CICC: Lowering the target price of Weigao shares to HK$7.5 last year's performance is clearly under pressure
Goldman Sachs: Maintaining the “Buy” Rating of Weigao Shares (01066) and reducing the target price to HK$10
Weigao Co., Ltd. (01066.HK): 2023 performance is clearly under pressure, waiting for stable performance in 2024
Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
Shandong Weigao Group Medical Polymer Co (SHWGF) Gets a Buy From Jefferies
Jefferies Reaffirms Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)
Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
Weigao Co., Ltd. (01066.HK): Revenue declined slightly year-on-year in the first half of the year and implemented platformization, internationalization and digitalization strategies
Changes in Hong Kong stocks | Weigao Shares (01066) fell nearly 4%, net profit fell by about 21.3% year-on-year in the first half of the year, and many major banks lowered target prices
DBS Ratings | DBS: Lowering the target price of Weigao shares to HK$11.6 and “buy”
Bank Ratings | Furui: Lowers the target price of Weigao shares to HK$17 and “buy”
Bank Ratings | Citigroup: Lowers the target price of Weigao shares to HK$13 and “buy”
Weigao Co., Ltd. (1066.HK): Performance declined year-on-year due to the impact of orthopedic sector collection
Weigao Co., Ltd. (1066.HK): Performance declined year-on-year due to the impact of orthopedic sector collection
Analysis
Price Target
No Data
